MedTech Outlook Magazine: Specials Magazine

For many years, manual therapy techniques have been the cornerstone of treatments for musculoskeletal issues, ranging from joint pain to scar tissue rehabilitation. However, the challenge of reaching deeper tissue layers that cannot be addressed by hands-on methods has always remained. It was this gap in therapeutic outcomes that Stefan Deny, a medical practitioner, inventor, and creator of the innovative Pneumatic Pulsation Therapy (PPT), noticed early in his career. Deny’s clinical observations revealed that traditional manual techniques often fell short of penetrating the deeper layers of tissue that are crucial for long-term healing and pain relief. He recognized that solving this problem required not just better tools, but an entirely new approach. Through years of research and experimentation, Deny discovered that applying a precise frequency of around 200 pulsations per minute could stretch tissue vertically from the inside out. This breakthrough made it possible to reach depths previously unattainable, while remaining both effective and reproducible for regular use. In 1993, Deny’s work led to the founding of Pneumed GmbH by his daughter, Barbara Deny-Jahnke, as a family-owned company rooted in his clinical experience and vision. Based in Idar-Oberstein, Germany, Pneumed has built a legacy centered on combining clinical research with precision engineering to create solutions that reshape the therapeutic landscape. Today, Pneumed’s flagship product, the pneumatron^® 200, is a unique medical massage device built around a mechanically precise pneumatic pulsation that stretches tissue vertically from the inside out, reaching depths manual techniques cannot, while remaining simple and repeatable in daily use. Proven effective across numerous therapeutic applications, it has become a cornerstone in physiotherapy, occupational and hand therapy rehabilitation, sports medicine, medical cosmetics, and wellness settings.

For people living with lipedema or lymphedema, treatment failure rarely comes from a lack of options. It comes from the fact that most therapies are impossible to maintain in real life. Clinic-based schedules, appointment availability and fragmented care pathways often make continuity difficult, even when effective treatment exists. Venen Engel was designed around one insight: compression therapy only works if people can actually stick with it. Rather than organising compression therapy around clinic visits, it structured its model around everyday use through its full-length compression pants and programmable pneumatic system. That design makes therapy easier to repeat, emotionally sustainable and accessible within daily life. The result is not a device people schedule, but a system they rely on, one that turns clinically proven compression into a daily habit rather than an occasional intervention. “There is something powerful about knowing relief is always close by when your legs start to feel heavy,” says Helge Meyer, managing director. “Patients often refer to our system as their ‘best friend,’ which reflects what happens when therapy stops being something people have to arrange and becomes something they can rely on.” Treating the Whole Pathway, Not Isolated Segments Traditional compression systems often focus on the lower leg, stopping at the calf or knee. Venen Engel takes a different anatomical approach. Its full-length compression pants begin at the feet and extend past the hips and over the lower abdomen, because effective lymphatic drainage does not stop at the knee, and neither should compression therapy..